UKHSA warns: How antidepressants and other drugs can raise your risk in hot weather
And this isn't just an elder-living-in-a-care-home problem—it's for anyone in sunny conditions taking these meds.
Normally, your body cools itself by sweating, adjusting blood flow near your skin, and maintaining fluid balance. But certain medications mess with these systems and can throw your internal thermostat off balance.
Take diuretics and blood pressure drugs like ACE inhibitors, beta-blockers, or calcium channel blockers.
These meds can dehydrate you by increasing urination, suppressing thirst, and limiting blood flow shifts. That means less sweating, less cooling—and less ability to roll with soaring temps. The MHRA (Medicines and Healthcare products Regulatory Agency) specifically calls out these drugs as raising your heat risk during warm spells.
Then you've got mental health drugs—SSRI and TCA antidepressants, antipsychotics, and ADHD stimulants like methylphenidate.
They can stop your body from sweating enough, boost your core temperature, and make it harder for your brain to detect overheating.
Even antibiotics like doxycycline ramp up sun sensitivity, making a short walk outside unexpectedly scorching. Meanwhile, NSAIDs and some supplements put extra stress on your kidneys during dehydration—meaning your meds can make the heat hit harder than usual.
When pills go off script in the heat
It's not just about side effects.
Heat itself can degrade medication. Insulin, and certain antibiotics can become less effective if stored above recommended temps—usually around 25°C. Picture leaving your insulin vials baking in a hot car or your pills in a backpack at the beach. The MHRA warns these medications can lose potency, or even become dangerously unstable.
Heatproofing your health routine
So what should you do if you're on these meds and the thermometer spikes?
Start with storing meds properly.
Keep them out of direct sunlight, avoid cars in midday heat, and check that bottles haven't changed color or texture. Know where your fridge's cooler spots are, and move meds into them when needed.
Then there's personal heat readiness. Stay hydrated and don't wait until you're thirsty—those on diuretics or antihypertensives might not feel typical thirst signals. Look out for dizziness, headaches, confusion, or dark urine: classic heat-exhaustion signs.
If you're on any meds that affect your body's heat response—SSRIs, beta-blockers, ADHD meds—think ahead. Limit outdoor time during peak sun hours from 11am to 3pm. Stick to light clothing, stay in shade, and chill out indoors when the heat's too much.
Who's most at risk?
This isn't just doom-saying. Heat-health alerts like the UK's yellow and amber warnings are being issued more frequently, and the public health impact is real. England recorded over 1,300 heat-related deaths last summer, and medicines were a big contributor.
Elderly people, kids, those with chronic conditions, or anyone on multiple medications—especially those for blood pressure, mental health, or diabetes—are the most vulnerable. But if you enjoy festivals, outdoor work, or travel, heat and pills could pose overlooked hazards.
A prescription for summer safety
What if everyone had a 'heat plan' alongside their morning meds? The
CDC
suggests that clinicians discuss temporary dose adjustments, hydration plans, and clear hot-weather check-ins with high-risk patients.
Likewise, the UKHSA encourages pharmacists and health professionals to proactively reach out ahead of heatwaves with leaflets, alerts, and storage guidance.
Even simple moves—keeping extra water by your bed, storing meds in a cool place, or turning on the fan during midday—can make a big difference when the mercury rises.
Heat is a drug amplifier
If you're breezing out in the sun this summer, your medication isn't just a pill in a cabinet—it's part of how your body reacts to heat. The UKHSA really isn't joking when they stress the double-whammy of high temps and everyday meds.
Because in sweltering summer, keeping cool is about more than comfort—it's about staying safe while on the meds that help you live your best life.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 days ago
- Time of India
Insomnia may be an overlooked factor in poor quality of life among adults with ADHD, says new study
A new study has found that insomnia and poor sleep quality may be key contributors to the reduced quality of life experienced by adults with attention deficit hyperactivity disorder (ADHD). The research, published in BMJ Mental Health, was led by experts from the University of Southampton in the UK and the Netherlands Institute for Neuroscience. ADHD and insomnia in adults: What's the link? ADHD is a neurodevelopmental disorder commonly diagnosed during childhood or adolescence. It is marked by symptoms such as impulsivity, inattention, and hyperactivity. However, growing evidence indicates that these symptoms persist into adulthood for many individuals, often accompanied by sleep problems. According to the study , adults with ADHD traits, particularly inattention and hyperactivity, were more likely to suffer from insomnia, poor sleep quality, and delayed sleep-wake cycles. These disruptions, in turn, were linked to a lower overall quality of life. Study shows how insomnia worsens quality of life in adults with ADHD Researchers analysed data from 1,364 middle-aged and older adults who were part of the Netherlands Sleep Registry. Participants answered detailed questionnaires about their sleep habits, ADHD symptoms, circadian rhythms (body clock), depression levels, and overall life satisfaction. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Is it legal? How to get Internet without paying a subscription? Techno Mag Learn More Undo The results revealed several striking patterns: Adults with ADHD symptoms reported more severe insomnia. These individuals were more likely to be 'night owls,' preferring to go to bed and wake up late. Poor sleep quality and insomnia were closely tied to a reduced sense of well-being and satisfaction with life. The researchers concluded that insomnia severity plays a major role in mediating the link between ADHD symptoms and lower quality of life. How ADHD and insomnia create a vicious cycle Dr. Sarah L. Chellappa, associate professor of psychology at the University of Southampton and senior author of the study, emphasised the two-way relationship between ADHD and sleep disturbance. 'Sleep disruption can impair attention and emotional regulation. At the same time, impulsivity and hyperactivity in ADHD may worsen sleep problems,' she explained. This feedback loop creates a reinforcing cycle, where ADHD worsens insomnia, and poor sleep exacerbates ADHD symptoms. The study further highlighted that adults with ADHD are nearly eight times more likely to be diagnosed with a sleep disorder compared to the general population. Common sleep-related symptoms in ADHD include Difficulty falling asleep Increased movement during sleep Shorter sleep durations Daytime sleepiness Why people with ADHD are more prone to insomnia The study also explored why adults with ADHD are more vulnerable to sleep problems. Researchers believe several biological and behavioural mechanisms may be involved. These include: Differences in cognitive processing Genetic variations affecting circadian rhythms and sleep cycles These factors may make it harder for people with ADHD to get restorative, high-quality sleep, affecting mood, concentration, and resilience. Treating insomnia to improve life quality in adults with ADHD Dr. Samuele Cortese, co-author of the study, stressed the importance of treating insomnia as part of ADHD management. 'Adults with ADHD traits often report poor sleep, low mood, and reduced well-being. These need to be addressed holistically,' he said. The research suggests that targeting insomnia in adults with ADHD may significantly improve their overall quality of life. Treatments may include: Cognitive behavioural therapy for insomnia Circadian rhythm regulation strategies ADHD medication adjustments Mindfulness or behavioural interventions This study adds to growing evidence that ADHD is not just about focus or hyperactivity, it has major implications for sleep health and emotional well-being. Recognising insomnia as a core issue may lead to more comprehensive and effective treatment strategies for adults living with ADHD. In the meantime, professionals recommend that healthcare providers routinely screen for sleep disturbances in adults diagnosed with ADHD and tailor treatment plans accordingly. Addressing sleep may be the missing key to unlocking better life outcomes for many. Also Read: 9 health benefits of asparagus you should know
India.com
3 days ago
- India.com
Silent Tsunami: The Return Of A Killer Germ That No Drug Can Stop
New Delhi: In the world of medicine, some enemies disappear quietly. Others evolve, hide in plain sight and return stronger. Typhoid fever is one of them. Once tamed by antibiotics, this ancient killer is back with a vengeance. It does not knock. It does not wait. And this time, the drugs do not work. In hospitals across the United Kingdom (England, Wales and Northern Ireland), a pattern has begun to emerge. Not a fluke. Not a seasonal spike. But a steady and quiet surge. The UK Health Security Agency (UKHSA) has reported 702 confirmed cases of typhoid and its cousin, paratyphoid fever, in 2024 alone. That is an 8% jump from the year before. It is the highest count ever seen. The source is not homegrown. This is not an outbreak tied to any one British city. Most of the infections were picked up abroad. Travellers are bringing it back, unwittingly, after visiting regions where the disease still thrives in water and food. But now there is a new twist – the old treatments no longer work. Typhoid is morphing into something scientists fear – a resistant and borderless predator. Much of the threat today comes from Pakistan, where doctors are facing a terrifying challenge. The typhoid strain spreading there is no longer afraid of our antibiotics. Not even the newest ones. This strain, now called extensively drug-resistant Typhi or XDR Typhi, does not respond to the usual weapons – ampicillin, chloramphenicol, trimethoprim, fluoroquinolones or even cephalosporins. These used to be life-savers. Now they barely scratch the surface. A team of researchers led by Stanford's Dr. Jason Andrews studied nearly 3,500 bacterial samples collected from Nepal, Bangladesh, India and Pakistan between 2014 and 2019. What they saw was eye-opening. The number of drug-defiant typhoid strains is growing fast. They are replacing treatable ones. And they are not staying local. The study revealed something more chilling – these mutated bacteria are on the move. Since 1990, scientists have tracked nearly 200 instances of international spread. Southeast Asia. East Africa. Southern Africa. And now, Western countries. Yes, even in the United Kingdom, the United States and Canada, typhoid superbugs are starting to show up. Every plane ticket. Every border crossing. Every contaminated sip or bite. The bacteria need only one chance. Globally, typhoid and paratyphoid infect around 13 million people every year. Over 1.3 lakh people lose their lives, most of them children in Asia and Africa. Despite its scale, typhoid rarely makes headlines. But that silence is dangerous. Especially now. The only treatment left is oral antibiotics. But their power is fading. Over three decades, the bacteria have gradually built resistance. They have learned. Adapted. And now, they are spreading those learnings across borders. The UKHSA data is just one part of the puzzle. Researchers say there are large blind spots, particularly in regions like sub-Saharan Africa and Oceania. We simply do not have enough bacterial samples from these places. Even in better-monitored countries, the samples usually come from just a handful of sites. That is like trying to map a wildfire by staring at a single tree. That lack of information means something troubling – we may be underestimating the scale of resistance and how fast it is travelling. The bacteria's genes and the mutations that make it immune are quietly crossing oceans. And we are not watching closely enough. Dr. Andrews calls this a 'real cause for concern'. He is not exaggerating. The way these strains have spread shows that typhoid control is a global emergency. Surveillance needs to expand. So do new treatment strategies. And vaccines need to reach where the outbreak begins, not where it ends. We live in an age of mobility. People, goods and germs travel faster than ever.
Time of India
4 days ago
- Time of India
Ancient killer drug-resistant typhoid strains is becoming untreatable and spreading across the globe; study warns
Drug-resistant typhoid fever is spreading rapidly across borders, raising concerns among scientists and public health authorities. A recent UK Health Security Agency (UKHSA) report has identified a troubling rise in typhoid and paratyphoid fever cases, particularly in England, Wales, and Northern Ireland. Tired of too many ads? go ad free now These infections, traditionally associated with poor sanitation in developing countries, are now resurfacing with a vengeance, this time in the form of extensively drug-resistant (XDR) typhoid strains. Driven by antibiotic resistance and global travel, these Salmonella Typhi superbugs are posing a major challenge to current treatment protocols. Experts warn that the clock is ticking to contain the spread before it becomes a full-blown global crisis. Drug-resistant typhoid becomes global threat, study warns A groundbreaking 2022 study found that S. Typhi is developing resistance to nearly all classes of commonly used oral antibiotics. Researchers analysed 3,489 bacterial genomes from India, Pakistan, Nepal, and Bangladesh. The results showed a dramatic rise in XDR strains—those resistant to older drugs like ampicillin and chloramphenicol, and newer ones such as fluoroquinolones and third-generation cephalosporins. Perhaps most concerning is the worldwide spread of these superbugs. The study documented at least 197 instances of international dissemination of XDR Typhi since 1990. These strains have moved beyond South Asia to East and Southern Africa, Southeast Asia, and even into Western countries like the UK, USA, and Canada. The scale and speed of this spread indicate that antibiotic-resistant typhoid is no longer a regional issue—it is a global emergency. Tired of too many ads? go ad free now Lead author Dr. Jason Andrews of Stanford University warned that the rapid evolution and spread of drug-resistant typhoid demand immediate international intervention. He emphasised that containment efforts must go beyond national borders and include vaccination, sanitation improvements, genomic surveillance, and new drug development. UK records Typhoid surge in 2024 underscoring global health risk The UKHSA's 2024 data recorded 702 typhoid cases, marking an 8% increase from 2023—the highest number ever documented. Though most infections were acquired abroad, this spike emphasizes the global nature of the threat. Typhoid and paratyphoid fever are caused by Salmonella enterica serovar Typhi and are typically spread through contaminated food or water. According to the BBC, typhoid and paratyphoid; a fever caused nearly 13 million infections and 133,000 deaths annually. These diseases disproportionately affect school-aged children in Asia and Africa, though they are increasingly seen in wealthier nations due to intercontinental travel and migration. Despite their persistence, these illnesses often remain neglected by health systems in developed countries. Poor data undermines fight against drug-resistant typhoid The study also highlights data limitations. Several regions, particularly in sub-Saharan Africa and Oceania, are underrepresented in genomic databases. Most available samples come from limited surveillance sites, meaning that current estimates likely understate the true scale of drug-resistant typhoid's spread. Scientists are calling for expanded genomic sequencing and international data sharing to track and curb these deadly strains more effectively. With antibiotic resistance rising, XDR typhoid now represents one of the biggest microbial threats of our time. While vaccines and improved public health systems can slow its advance, only a coordinated, global effort will prevent this ancient killer from claiming more lives in a modern world ill-prepared for it. Also Read |
